{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:45:17Z","timestamp":1761561917991,"version":"3.44.0"},"reference-count":26,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[1999,4,8]]},"published-print":{"date-parts":[[1999,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>To study the incidence and mode of onset of early reinitiation of atrial fibrillation (ERAF) following successful internal cardioversion of chronic atrial fibrillation, and to determine the effects of sotalol in the prevention of ERAF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>DESIGN<\/jats:title>\n                  <jats:p>The incidence and modes of onset of ERAF and the acute effects of intravenous sotalol in the prevention of ERAF were studied retrospectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SETTING<\/jats:title>\n                  <jats:p>Electrophysiology laboratory at a university teaching hospital.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PATIENTS<\/jats:title>\n                  <jats:p>64 patients, mean (SD) age 62 (10) years, who underwent internal cardioversion of chronic atrial fibrillation (mean duration of atrial fibrillation 31 (39) months).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN OUTCOME MEASURES<\/jats:title>\n                  <jats:p>ECGs and  intracardiac electrograms recorded during the internal cardioversion of atrial fibrillation using 3\/3 ms biphasic, R wave synchronised shocks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>52 patients (81%) had successful electrical cardioversion, and 20 (31%) of these had ERAF during the procedure. There was no clinical predictor for the occurrence of ERAF. Fifty eight episodes of ERAF were observed. Five ERAF episodes (9%) had preceding bradycardia and 53 (91%) of these were triggered by atrial premature beats with normal preceding heart rate. Atrial premature beats that reinitiated atrial fibrillation had a shorter coupling interval (333 (43) ms<jats:italic>v<\/jats:italic> 396 (100), p\u2009&lt;\u20090.001) and a lower prematurity index (0.44 (0.11) <jats:italic>v<\/jats:italic> 0.55 (0.14), p\u2009&lt;\u20090.001) than those that did not reinitiate atrial fibrillation. Repeated shock delivery and increasing the defibrillation energy did not prevent ERAF. Intravenous sotalol infusion decreased the numbers of atrial premature beats and prolonged their coupling interval, and prevented ERAF after repeated defibrillation in 83% of patients with ERAF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>ERAF is a significant clinical problem after successful internal cardioversion of chronic atrial fibrillation, and was observed in up to 31% of patients. In most episodes, ERAF was triggered by short coupling atrial premature beats with preceding normal heart rate. Intravenous sotalol was effective in preventing ERAF in most cases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/hrt.82.3.319","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T15:31:45Z","timestamp":1413991905000},"page":"319-324","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":55,"title":["Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol"],"prefix":"10.1136","volume":"82","author":[{"given":"H-F","family":"Tse","sequence":"first","affiliation":[{"name":"aDepartment of Medicine, Division of Cardiology, University of Hong Kong, Queen Mary Hospital, Hong Kong, China, \n\nbInControl Inc, Redmond, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-P","family":"Lau","sequence":"additional","affiliation":[{"name":"aDepartment of Medicine, Division of Cardiology, University of Hong Kong, Queen Mary Hospital, Hong Kong, China, \n\nbInControl Inc, Redmond, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Ayers","sequence":"additional","affiliation":[{"name":"aDepartment of Medicine, Division of Cardiology, University of Hong Kong, Queen Mary Hospital, Hong Kong, China, \n\nbInControl Inc, Redmond, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1999,9,1]]},"reference":[{"key":"2025092006490258000_82.3.319.1","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/j.1540-8159.1991.tb02730.x","article-title":"Effects of trans-catheter cardioversion on chronic lone atrial fibrillation.","volume":"14","author":"Kumagai","year":"1991","journal-title":"PACE"},{"key":"2025092006490258000_82.3.319.2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00555-5"},{"key":"2025092006490258000_82.3.319.3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1540-8159.1997.tb05492.x","article-title":"Hemodynamic effects and clinical determinants of defibrillation threshold for low energy transvenous atrial defibrillation in patients with chronic atrial fibrillation.","volume":"20","author":"Lok","year":"1997","journal-title":"PACE"},{"key":"2025092006490258000_82.3.319.4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0735-1097(96)00583-9","article-title":"Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation.","volume":"27","author":"Levy","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2025092006490258000_82.3.319.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.1.253"},{"key":"2025092006490258000_82.3.319.6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1540-8159.1994.tb01462.x","article-title":"Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation.","volume":"17","author":"Alt","year":"1994","journal-title":"PACE"},{"key":"2025092006490258000_82.3.319.7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.CIR.86.5.1415","article-title":"A randomized comparison of external and internal cardioversion of chronic atrial fibrillation.","volume":"86","author":"Levy","year":"1992","journal-title":"Circulation"},{"key":"2025092006490258000_82.3.319.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00274-4"},{"key":"2025092006490258000_82.3.319.9","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00230-6"},{"key":"2025092006490258000_82.3.319.10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1540-8167.1998.tb00893.x","article-title":"Immediate reinitiation of atrial fibrillation following internal atrial defibrillation.","volume":"9","author":"Timmermans","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025092006490258000_82.3.319.11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1540-8159.1998.tb00157.x","article-title":"Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation.","volume":"21","author":"Sra","year":"1998","journal-title":"PACE"},{"key":"2025092006490258000_82.3.319.12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1540-8159.1997.tb06084.x","article-title":"A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold.","volume":"20","author":"Lau","year":"1997","journal-title":"PACE"},{"key":"2025092006490258000_82.3.319.13","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.29.4.469"},{"key":"2025092006490258000_82.3.319.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.41.6.981"},{"key":"2025092006490258000_82.3.319.15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-8703(71)90314-0","article-title":"The onset of atrial fibrillation in man.","volume":"82","author":"Kennedy","year":"1971","journal-title":"Am Heart J"},{"key":"2025092006490258000_82.3.319.16","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(92)90112-G"},{"key":"2025092006490258000_82.3.319.17","unstructured":"Mehra R Hill M (1996) Prevention of atrial fibrillation\/flutter by pacing techniques. in Interventional electrophysiology. A textbook. eds Saksena S Luderitz B (Futura Publishing Co, New York), pp 521\u2013540."},{"key":"2025092006490258000_82.3.319.18","unstructured":"Murgatroyd F (1997) Mode of onset of spontaneous episodes of atrial fibrillation: implications for the prevention of atrial fibrillation by pacing. in Prevention of tachyarrhythmias with cardiac pacing. eds Daubert JC Prystowsky EN Ripart A (Futura Publishing Co, New York), pp 53\u201365."},{"key":"2025092006490258000_82.3.319.19","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.16.1651"},{"key":"2025092006490258000_82.3.319.20","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.7.1600"},{"key":"2025092006490258000_82.3.319.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-6-199709150-00001"},{"key":"2025092006490258000_82.3.319.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(83)80226-5"},{"key":"2025092006490258000_82.3.319.23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.CIR.69.1.26","article-title":"Facilitation of macroreentry within the His-Purkinje system with abrupt changes in cycle length.","volume":"69","author":"Denker","year":"1984","journal-title":"Circulation"},{"key":"2025092006490258000_82.3.319.24","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1540-8159.1988.tb06289.x","article-title":"DDD pacing: an effective treatment modality for recurrent atrial arrhythmias.","volume":"88","author":"Attuel","year":"1988","journal-title":"PACE"},{"key":"2025092006490258000_82.3.319.25","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0735-1097(98)00691-3","article-title":"Defibrillation guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus.","volume":"33","author":"Lau","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2025092006490258000_82.3.319.26","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.3.572"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.82.3.319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T13:49:12Z","timestamp":1758376152000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.82.3.319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9,1]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1999,9,1]]},"published-print":{"date-parts":[[1999,9,1]]}},"alternative-id":["10.1136\/hrt.82.3.319"],"URL":"https:\/\/doi.org\/10.1136\/hrt.82.3.319","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[1999,9,1]]}}}